TSC2 and tuberous sclerosis: The disease results from a variety of loss-of-function mutations in the tumour suppressor genes TSC1 and TSC2, with more than 200 TSC1 and nearly 700 TSC2 unique allelic variants having been identified in TSC patients thus far [2, 3].